Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Norwegian University of Science and Technology
With
Haukeland University Hospital
University Hospital of North Norway
St. Olavs Hospital
Age
18–any
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Prostate cancer patients with biochemical relapse in accordance with the European Association of Urology (EAU) guidelines on prostate cancer; two consecutive measurements with PSA ≥ 0.2 ng/ml following radical prostatectomy or PSA \> 2.0 ng/ml above the nadir following definitive radiotherapy
Potential candidates for loco-regional pelvic salvage treatment based on age and co-morbidity
You may not be if
Previous salvage therapy for recurrent prostate cancer
General contra-indications for an MRI exam (pacemaker, aneurysm clips, any form of metal in the body, or severe claustrophobia)
Serious concomitant systemic disorders or reduced cognitive functioning that in the opinion of the investigator would compromise the patient's ability to complete the study or interfere with the evaluation of the efficacy and safety of the study objectives
Impaired renal function defined as estimated glomerular filtration rate (eGFR) \< 30 ml/min/1.73 m2
Hormonal treatment during the last three months
Clareo Health | PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical Treatment
